LG CNS launches 'RX Innovation Lab,' moving into full-scale robot consulting

[The Financial News] LG CNS has created a dedicated organization to support companies in planning and executing their robot adoption strategies, and is expanding its robot transformation (RX) business.
LG CNS announced on the 1st that it has launched the "RX Innovation Lab," which provides customized consulting on robot adoption for clients. The RX Innovation Lab identifies ways to use robots that fit a company's work environment and adoption goals, and supports the entire pre-adoption process of RX, from redesigning workflows to reviewing productivity through proof-of-concept (PoC).
Through the RX Innovation Lab, LG CNS offers a three-stage program that helps customers establish optimal robot transformation strategies. In the INSIGHT stage, it analyzes the client’s industry characteristics, on-site environment, and work processes to identify areas where robots can be introduced. In the DESIGN stage, it selects the most suitable robot solutions, such as autonomous mobile robots (AMR) and humanoid robots, and redesigns workflows by defining the division of roles between humans and robots and incorporating safety and quality standards. In the PROOF stage, it trains robots using worker behavior data, then systematically evaluates feasibility for real-world deployment, productivity, safety, and operational efficiency through robot system implementation and PoC.
In particular, LG CNS is pursuing RX not just as simple automation of individual processes, but by redesigning workflows across entire operations. For logistics companies, it analyzes every step from inbound and storage to sorting, picking, packing, and outbound, identifies sections where robots can have the greatest impact, and converts factors such as travel routes, processing time, and human–robot collaboration zones into data to design the optimal process sequence and task allocation.
With this new organization, LG CNS has completed a support framework that helps corporate clients innovate across DX, AI Transformation (AX), and RX. The launch of the RX Innovation Lab gives the company a comprehensive innovation lineup that spans digital technologies, AI, and robotics.
LG CNS is also rapidly strengthening its Physical AI capabilities, which underpin robot transformation. To advance its industry-specific robot foundation model, it has expanded partnerships with Skild AI, a U.S. developer of robotic brain technology, and Config, a company specializing in dual-arm control Robotics Foundation Models (RFM) for humanoid robots. After independently developing a robot integrated operation platform that controls, manages, and operates heterogeneous robots, the company made a strategic investment this year in U.S. humanoid robot firm Dexmate, securing hardware design capabilities as well. Based on this, LG CNS plans to offer a full-stack RX service that combines RFM, platforms, and hardware, the three core elements of robot commercialization.
Hyun Shin-gyun, CEO of LG CNS, stated, "The essence of robot transformation lies not in simple automation, but in redesigning and innovating productivity from the perspective of the entire work process," adding, "Leveraging our Physical AI capabilities, LG CNS will build RX models optimized for industrial sites and help our customers improve productivity and accelerate growth."
jiany@fnnews.com Yeon Ji-an Reporter